- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02374723
Evaluation of Biosynthetic Constructs to Replace Donor Corneas
Evaluation of Biosynthetic Constructs as Replacement for Donor Corneas as Graft Material for Corneal Transplantation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
12 patients will be recruited from the waitinglist for corneal transplantation.The will all be of the age of 18 years or older and capable of making their own decisions. Their medical history and present medication is reveiwed and they undergo a thorough ophthalmological examination in order to find out if they meet the inclusion criteria and create baseline values for the study. Their general health or medication should not affect the cornea or ocular surface. The Eye should be healthy with the exception of the disease indication for corneal grafting. The corneal endothelium should be healthy. Any opacification in the eye to be grafted should not reach the Descemets membrane. Visual acuity in the fellow eye should be good. If these criteria are met the patient recieve oral and written information of the study. If they agree to participate they will be randomized to either recieve biosynthetic corneas ( 6 patients) or they will recieve a donated cornea ( 6 patients) . They will be scheduled for surgery within 2 weeks from the examination irrespective if they participate in the study or not.
The surgery will be anterior deep lamellar using the femtosecond laser to do the patient cut. The laser cut wil be done in topical anaaestesi. The remaining surgery with either be performed in local oor general anaestesia according to the patients wish. The diameter of the cut will be 7 mm in diameter. The graft material will be punched to a diameter of 7.25 mm. The thickness of the material will be 500 µm . An amniotic membrane will be placed on the top of the biosynthetic material and sutured with single stiches together with the graft.A bandage lens will be placed . The donated corneas will be sutured with singled about 8 stiches.
The biosynthetic corneas will recieve topical antibiotics and dexametasone for 8 weeks when the sutures, remnants of the amniotic membrane and the bandage lens is removed. The donated corneas will recieve topical dexametasone for 5 months and the sutures will be removed after 6 months.
The check-up Schedule will be at 1 day,1,2 weeks,1,,2 months and extra when needed.The protocol in these check-ups will be descriptive and the exyes will be documented with slit lamp photography. Epitelialisation will be monitored with fluorescein staining.
At the 3,6,9 and12 months will be extensive and the same in both groups. UCVA and BSCVA will be measured and also BCLCVA at 12 months. Corrneal topography,thickness sensitivity,tear production Visante OCT and slit- lamp photography will be performed. Tear samples will be taken also form earlier check-ups for proteomic analysis. In vivo confocal microscopy will be performed. The different examination with few exceptions can all be presented in results that can be quantified and statistically analysed.
The CRFs and the adverse report forms will be filled out both on computer forms and on paper.
The safety outcome criteria are: Good engraftment, maintained integrity of the graft, epithelialisation, transparency,no induced inflammation,no induced vasculatisation.
The preliminary efficacy criteria are: UCVA,BSCVA and BCLCVA
Study Type
Phase
- Phase 1
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Indication for Deep anterior lamellar corneal transplantation.
- No topical Eye medication.
Exclusion Criteria:
- No Eye disease other than the indication for the corneal graft.
- No general disease that might affect the cornea.
- No general medication that might affect the cornea.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: NuCornea (Biosynthetic corneas)
6 patients will receive biosynthetic corneas when undergoing corneal transplantation
|
Deep anterior lamellar corneal transplantation where the NuCornea is substituting a donor cornea
Other Names:
|
ACTIVE_COMPARATOR: Donated human corneas
6 patients will receive a donated human cornea when undergoing corneal transplantation
|
Deep anterior lamellar corneal transplantation with a donated cornea as graft material.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biocompatibility: Good engraftment,epithelialization, no neovascularization,retained transparency, no host inflammatory reaction
Time Frame: 1 year
|
Device replacing human donor cornea at Deep anterior lamellar transplantation.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual acuity
Time Frame: 1 year
|
Best spectacle corrected visual acuity,Best contactlens corrected Visual acuity
|
1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Per Fagerholm, MD,PhD, Dept of Ophthalmology, University Hospital, Linköping,Sweden
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DNr52120125706
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Disease
-
Umeå UniversityGlaukos CorporationCompletedEye Diseases | Keratoconus | Corneal Disease | Corneal Crosslinking | Corneal Biomechanics | Corneal Densitometry | Scheimpflug PhotographySweden
-
Tianjin Eye HospitalRecruitingDeep Learning, Corneal Disease, ScreeningChina
-
University Hospital FreiburgGerman Research FoundationCompleted
-
E-DA HospitalCompletedCorneal DiseasesTaiwan
-
National Eye Institute (NEI)Completed
-
Umeå UniversityGlaukos CorporationActive, not recruitingEye Diseases | Keratoconus | Corneal Crosslinking | Corneal Densitometry | Scheimpflug Photography | Corneal DisorderSweden
-
Federal University of São PauloCompleted
-
Benha UniversityCompleted
-
Nidek Co. LTD.CompletedGlaucoma | Retinal Disease | Corneal DiseaseUnited States
-
Keratoplasty Alliance InternationalRecruitingCorneal Disease | Corneal Transplant Failure | Endothelial Corneal Dystrophy | Corneal Transplant RejectionUnited States